Please login to the form below

Janssen

This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.

Moderna expects to supply 125 million COVID-19 vaccine doses in Q1 2021

So far, the UK has secured access to COVID-19 vaccine candidates from AstraZeneca, BioNTech/Pfizer, Novavax, Valneva, GlaxoSmithKline/Sanofi Pasteur and Janssen, as well as Moderna.

Latest news

Moderna and UK sign agreement for additional doses of COVID-19 vaccine

So far, the UK has secured access to potential COVID-19 vaccine candidates from AstraZeneca, BioNTech/Pfizer, Novavax, Valneva, GlaxoSmithKline/Sanofi Pasteur and Janssen, as well as Moderna.
UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’

The vaccine taskforce has so far secured access to six potential COVID-19 vaccines, including candidates from AstraZeneca and Oxford University, Pfizer and BioNTech, Janssen, Novavax, GlaxoSmithKline and Sanofi and Valneva.
J&J advances COVID-19 vaccine into phase 3 testing

We used a highly scientific and evidence-based approach to select this vaccine candidate,” said Mathai Mammen, global head, Janssen Research &Development, J&J.
Phase 1/2a results for J&J’s COVID-19 vaccine show early promise

Researchers from J&J’s pharmaceutical division Janssen said, from data available at the interim analysis, 98% of participants had neutralising antibodies 29 days after vaccination.
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Positive interim results presented at 2020 ESMO virtual congress. Janssen, the pharmaceutical division of Johnson &Johnson, has revealed positive interim results from a phase 1 study of its investigational bispecific antibody ... NSCLC. Janssen assessed

More from news
Approximately 135 fully matching, plus 397 partially matching documents found.

Latest Intelligence

Unlocking the potential of precision medicine in oncology

Joaquín Casariego García-Lubén talks to PME about how Janssen is driven by the premise of providing personalised treatment solutions in cancer care. ... Joaquín Casariego García-Lubén is EMEA Therapeutic Area Lead Oncology, The Janssen
Switzerland: a life sciences hub

The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.
Will biosimilars ever catch on in the US?

Pfizer also cited a Janssen brochure that allegedly implied the biosimilar Inflectra is not interchangeable with Remicade and may pose a safety risk.
The first, my last, my everything

It’s a subtle but important nuance. It’s a similar story elsewhere, with companies like Roche, Janssen and MSD ‘partnering with patients’ to understand their needs and identify opportunities for
Brain power: fresh approaches to Alzheimer’s drug discovery

Katrin Haeverans, EPAD LCS and POC platform support, Janssen said: “EPAD has been built to facilitate proof-of-concept trials. ... Sir Simon Lovestone. After 18 years in old age psychiatry and dementia research in academia, Sir Simon Lovestone joined

More from intelligence
Approximately 5 fully matching, plus 52 partially matching documents found.

Latest appointments

Ex-J&J exec Denice Torres joins bluebird bio’s board

During her time at J&J, Torres held several executive leadership roles including president of McNeil Consumer Healthcare and president of Janssen Pharmaceuticals, CNS.
New hires at Bristol-Myers Squibb, Acceleron and FerGene

He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his career at Johnson &Johnson and Janssen.
Robert Freisen joins Ablynx

He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.
Mundipharma appoints Dr Alberto Martinez as president and CEO

Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.
Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

He will lead a team of business development managers focused on areas such as multichannel marketing and NHS service redesign and join from Janssen Pharmaceuticals. ... Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where he served in a

More from appointments
Approximately 3 fully matching, plus 26 partially matching documents found.

Latest from PMHub

OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020

READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:. The Immunology Training Summit (ITS) 2020 with the Janssen EMEA Immunology team took a week-long face-to-face meeting for ... Strikingly this format is now considered best practice in
Attigo (part of the Mednet Group)

Clinigen. Crohns and Colitis Department for International Development. Eisai. Gilead. Janssen.
If our patients are diverse, why are clinical trials so white?

Darzalex is made by Janssen Oncology, a company under Johnson &Johnson. ... Janssen are not alone in trying to make clinical trials more representative.
Havas Lynx Group

Grϋnenthal. Janssen. Lilly. Lundbeck. Merck Serono. Novartis. Novo Nordisk. Pfizer. Roche.
EPG Health

Strategic planning - to ensure sustained engagement and ongoing success. Alexion, Almirall, Alnylam, AstraZeneca, Bial, Biogen, Bluebird Bio, Boehringer Ingelheim, BMS, CSL Behring, Ferring, Four Health, HRA Pharma, Janssen, Leo Pharma, Mylan,

More from PMHub
Approximately 5 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Senior Account Manager: Competitive

Healthcare Account Director: Competitive

Healthcare Lead Copywriter: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Account Director – Creative Healthcare Communications: Competative

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

PMHub

Add my company

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The pandemic preparedness paradox: Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Sourcing R&D innovation: why pharma companies need to evolve their business models: Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...